Skip Ribbon Commands
Skip to main content
Dr Chia Shulyn Claramae from National Cancer Centre Singapore

Dr Claramae Chia Shulyn

MBBS, MRCS (Edin), M Med (Surg), FRCS (Ed)


National Cancer Centre Singapore

Specialty: Surgical Oncology, Surgical Oncology

Sub-specialties: Upper Gastrointestinal, Colorectal, Peritoneal-based Malignancies, Sarcoma, Skin & Melanoma

Conditions Treated by this Doctor:
Colorectal Cancer, Melanoma, Peritoneal based Malignancies, Sarcoma, Skin Cancer, Upper Gastrointestinal Cancers.

Clinical Appointments

  • Consultant General Surgery Singapore General HospitalSingapore General Hospital
  • Consultant Division of Surgical Oncology National Cancer Centre SingaporeNational Cancer Centre Singapore

Academic Appointments

  • Fellow
  • Physician Faculty Member
  • Clinical Tutor
  • Adjunct Assistant Professor


Dr Claramae Chia is Consultant in the Division of Surgical Oncology, National Cancer Centre Singapore (NCCS). She graduated from the National University of Singapore(NUS) in 2005 and obtained her membership diploma for surgery in 2008 from the Royal College of Surgeons of Edinburgh. In May 2013, she completed her advanced surgical training and joined as a Fellow of the Royal College of Surgeons of Edinburgh. She went on to complete her subspecialty training in surgical oncology focused on peritoneal surface malignancies and was awarded the SingHealth Health Manpower Development Plan - Peritoneal Surface Malignancy Surgical Oncology Programme in 2013. 

She has been actively involved in clinical and basic research with publications in several peer-reviewed journals. In 2008, she joined the Wee Kim Wee Laboratory of Surgical Oncology at the NCCS as a clinical research fellow and won the Singapore Millennium Foundation Grant for Associate Investigator for her translational work in nasopharyngeal carcinoma which won the Young Surgeon’s Award 2013 at the 2nd AMM-AMS-HKAM Tripartite Congress & 47th Singapore Malaysia Congress of Medicine. Dr Chia is also a clinical tutor at the Yong Loo Lin School of Medicine in NUS and teaches Duke-NUS students who rotate through their general surgery rotation.


  • FRCS (Edinburgh), August 2012 
  • Master of Medicine(Surgery), July 2012 
  • National University of Singapore, Bachelor of Medicine and Bachelor of Surgery,  2000-2005

Professional Appointments and Committee Memberships

  • Member, Society of Surgical Oncology International, 2015
  • Member, European Society of Surgical Oncology, 2015
  • Medical Officer Committee, Singapore Medical Association, 2008 
  • Member, International Association of Surgeons, Gastroenterologists and Oncologist (IASGO), Sep 2014 to Present 
  • Surgeons-In-Training Committee Chairperson, Chapter of Surgeons Singapor, 2010 to Present 


  • Winner of Young Surgeon’s Award 2013
  • 2nd AMM-AMS-HKAM Tripartite Congress & 47th Singapore Malaysia Congress of Medicine, 2013
  • SingHealth Health Manpower Development Plan - Peritoneal Surface Malignancy Surgical Oncology Programme, 2013
  •  Singhealth Best Registrar Award, 2012
  • Singapore Millennium Foundation Scholarship (Associate Investigator), 2009
  • Singhealth House Officer Award at the 2006 Department of General Surgery, Singapore General Hospital, 2006
  • NUS Medical Society Colours Award, 2002

Publications and Research Trials

  • Wong YT, G Tan, C Chia, M Kumar, Soo KC, M Teo. Morbidity and Mortality of elderly patients following cytoreductive surgery and HIPEC. Asia-Pacific Journal of Clinical Oncology Article ID : AJCO12723, DOI : 10.1111/ajco.12723 
  • Tan, Grace; Shannon, Nicholas; Chia, Claramae; Soo, Khee Chee; Teo, Melissa. Platinum agents and mitomycin C specific complications in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).International Journal of Hyperthermia DOI: 10.1080/02656736.2017.1345014 
  • D Ng, G Tan, C Chia, Soo KC, R Quek, M Farid, M Teo. Tumour Biology remains the main determinant of prognosis in retroperitoneal sarcomas: a 14-year single-center experience. Asia-Pacific Journal of Clinical Oncology, 2017 March 30, doi: 10.1111/ajco.12662 
  • Tan Yu Guang; Tan Grace; Tan David; Chia Claramae S; Ang Dun Yong; Teo Melissa C C Urological reconstruction after pelvic oncological surgery: A single institution experience. Asian 2016 Jun 14. pii: S1015-9584(16)30029-X. doi:10.1016/j.asjsur.2016.02.002
  • Thong Sze Ying; Chia Claramae Shulyn; Ng Oriana; Tan Grace; Ong Ee Teng; Soo Khee Chee; Teo Melissa. A review of 111 anaesthetic patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Singapore medical journal 2016, 1–23 doi: 10.11622/smedj.2016078 
  • DWJ Ng, GHC Tan, CS Chia , CX Lim, KC Soo, RHH Quek, M Farid, M Teo Is the Memorial Sloan Kettering Cancer Centre (MSKCC) sarcoma nomogram useful in an Asian population? Asia-pacific Journal of Clinical Oncology 2016 November 21 (AJCO12607) DOI: 10.1111/ajco.12607 
  • Bong THS, G Tan, C Chia, Soo KC, M Teo. Preoperative Platelet-Lymphocyte Ratio is an Independent Prognostic Marker and Superior to Carcinoembryonic Antigen in Colorectal Peritoneal Carcinomatosis Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. European Journal of Surgical Oncology 2016; 22(3), 511-518 doi: 10.1007/s10147-017-1092-3 
  • Loh W L, G Tan, C Chia, M Teo. Prognostic Significance of Neutrophil/Lymphocyte Ratio (NLR) and Platelet/Lymphocyte ratio (PLR) in Predicting Outcomes for Peritoneal Carcinomatosis Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Asian Journal of Oncology, Epub ahead of print
  • Tan HL, C Chia, Tan HCG, M Teo. Gastric peritoneal carcinomatosis - a retrospective review of clinical features and treatment outcomes. Journal of Clinical Gastroenterology 2017 March 15 9 (3):121-128 DOI: 10.4251/wjgo.v9.i3.121 JIF: 1.48 
  • G Tan, C Chia, M Kumar, Choo SP, J Chia, Tham CK C Chua, Soo KC, M Teo.201 Consecutive Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Procedures in a Single Asian Tertiary Centre.Int J Hyperthermia.2016 Nov 17:1-22 JIF: 3.02

Research Trials

  • Evaluation of MRI versus CT or PET-CT in the detection of peritoneal disease malignancies